At a glance
- Originator LEO Pharma
- Class Antihypertensives; Guanidines
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 09 Nov 2000 Discontinued-Preclinical for Hypertension in Brazil (Unknown route)
- 18 Nov 1998 No-Development-Reported for Hypertension in Brazil (Unknown route)
- 08 Feb 1996 New profile